Wang Yuwei, Zhuo Changhua, Shi Debing, Zheng Hongtu, Xu Ye, Gu Weilie, Cai Sanjun, Cai Guoxiang
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200032, China.
Int J Colorectal Dis. 2015 Jan;30(1):131-7. doi: 10.1007/s00384-014-2056-y. Epub 2014 Nov 13.
We sought to determine the prognostic role of tumor size on cause-specific survival (CSS) of patients with stage IIA colon cancer.
Surveillance, Epidemiology and End Results (SEER) database was utilized to identify patients with stage IIA colorectal cancer (examined lymph nodes ≥12) diagnosed from 1988 to 2003. The prognostic effect of tumor size on CSS was evaluated by univariate and multivariate analyses.
A total of 8775 patients were enrolled in the analysis. The median follow-up time was 109 months. As determined by minimal P value method, tumor sizes of 2.5 and 6.0 cm were used as optimal cutoff value to divide the cohort. The 8-year CSS of colon cancer with tumor sizes ≤2.5, 2.6-6.0, and >6.0 cm was 81.6, 86.2, and 86.7% respectively (P = 0.003). In the multivariate analysis of colon cancer, using ≤2.5-cm tumors as reference, decreased hazard ratio (HR) of CSS was observed in 2.6-6.0 cm (HR, 0.736; 95% confidence interval (CI), 0.599-0.905; P = 0.004) and >6.0 cm (HR, 0.770; 95% CI, 0.619-0.958; P = 0.019) tumors.
In stage IIA colon cancer, small tumor size represented a subset with decreased CSS. Further studies are merited to validate the unfavorable prognostic role of small tumor size in stage IIA colon cancer.
我们试图确定肿瘤大小对IIA期结肠癌患者特定病因生存率(CSS)的预后作用。
利用监测、流行病学和最终结果(SEER)数据库,识别1988年至2003年诊断为IIA期结直肠癌(检查淋巴结≥12个)的患者。通过单因素和多因素分析评估肿瘤大小对CSS的预后影响。
共有8775例患者纳入分析。中位随访时间为109个月。通过最小P值法确定,将肿瘤大小2.5 cm和6.0 cm作为最佳截断值来划分队列。肿瘤大小≤2.5 cm、2.6 - 6.0 cm和>6.0 cm的结肠癌患者8年CSS分别为81.6%、86.2%和86.7%(P = 0.003)。在结肠癌的多因素分析中,以≤2.5 cm的肿瘤为参照,2.6 - 6.0 cm(风险比[HR],0.736;95%置信区间[CI],0.599 - 0.905;P = 0.004)和>6.0 cm(HR,0.770;95% CI,0.619 - 0.958;P = 0.019)的肿瘤患者CSS的风险比降低。
在IIA期结肠癌中,小肿瘤大小代表CSS降低的一个亚组。值得进一步研究以验证小肿瘤大小在IIA期结肠癌中的不良预后作用。